* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, September 18, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    REO to return for UI homecoming – The News-Gazette

    REO Gears Up to Ignite the Stage at UI Homecoming Celebration!

    Gen V Season 2: What is The Odessa Project? – yahoo.com

    Gen V Season 2: Unlocking the Secrets of The Odessa Project

    PENN Entertainment stock rating reiterated at Market Outperform by JMP – Investing.com

    PENN Entertainment Stock Rated a Market Outperformer by Experts

    Here’s how NJ’s once-vibrant nightclub scene was born and why it died – Bergen Record

    The Rise and Fall of New Jersey’s Once-Vibrant Nightclub Scene: What Happened?

    The Emmys are back: Viewership soars to highest numbers in 4 years – yahoo.com

    The Emmys Return with a Bang: Viewership Hits a 4-Year High

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

    Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

    City IT presented Best of North Carolina Technology Award – RaleighNC.gov

    City IT Honored with Best of North Carolina Technology Award

    LELO Releases 2025 Futurist Report: Intergenerational Views on Relationships, Sex, and Technology – PR Newswire

    Exploring the Future: How Different Generations View Relationships, Sex, and Technology in 2025

    Will New Big Technology Engagements Reshape Innodata’s Growth Path? – Yahoo Finance

    Could New Major Tech Partnerships Propel Innodata to Unprecedented Growth?

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    REO to return for UI homecoming – The News-Gazette

    REO Gears Up to Ignite the Stage at UI Homecoming Celebration!

    Gen V Season 2: What is The Odessa Project? – yahoo.com

    Gen V Season 2: Unlocking the Secrets of The Odessa Project

    PENN Entertainment stock rating reiterated at Market Outperform by JMP – Investing.com

    PENN Entertainment Stock Rated a Market Outperformer by Experts

    Here’s how NJ’s once-vibrant nightclub scene was born and why it died – Bergen Record

    The Rise and Fall of New Jersey’s Once-Vibrant Nightclub Scene: What Happened?

    The Emmys are back: Viewership soars to highest numbers in 4 years – yahoo.com

    The Emmys Return with a Bang: Viewership Hits a 4-Year High

    From Spinal Tap II to Ed Sheeran : your complete entertainment guide to the week ahead – The Guardian

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

    Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

    City IT presented Best of North Carolina Technology Award – RaleighNC.gov

    City IT Honored with Best of North Carolina Technology Award

    LELO Releases 2025 Futurist Report: Intergenerational Views on Relationships, Sex, and Technology – PR Newswire

    Exploring the Future: How Different Generations View Relationships, Sex, and Technology in 2025

    Will New Big Technology Engagements Reshape Innodata’s Growth Path? – Yahoo Finance

    Could New Major Tech Partnerships Propel Innodata to Unprecedented Growth?

    Unlocking AI Success: How People, Process, and Technology Form the Ultimate Triangle

    Billion-dollar coffins? New technology could make oceans transparent and Aukus submarines vulnerable – The Guardian

    Billion-Dollar Coffins? How New Technology Could Make Oceans Transparent and Expose Submarines

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Science

Scientists knew phenylephrine was useless—but you’ve been using it for decades

September 30, 2023
in Science
Scientists knew phenylephrine was useless—but you’ve been using it for decades
Share on FacebookShare on Twitter

Health

More than 200 over-the-counter decongestants contain a key ingredient that was just revealed to be ineffective—and cold and flu season is just around the corner. Now what?

ByStacey Colino

Published September 29, 2023

• 9 min read

The recent revelation that a common oral decongestant called phenylephrine doesn’t work has rattled consumers, especially as cold and flu season is imminent and COVID continues to make the rounds.

An ingredient in many over-the-counter (OTC) decongestants, phenylephrine is present in more than 200 different OTC products, including Sudafed PE, Vicks DayQuil, and NyQuil Severe Cold & Flu, Mucinex Fast-Max Severe Congestion and Cough, Tylenol Cold & Flu Severe, and many others. It’s in most products that claim to contain a decongestant, says Jason Talmadge, an ear, nose, and throat physician and assistant professor of otorhinolaryngology at UTHealth Houston.

In 2007, a group of pharmacists petitioned the Food and Drug Administration (FDA) to remove phenylephrine from the market, after presenting evidence of flaws in the original studies and a meta-analysis of studies showing there wasn’t a difference between the decongestant and placebo on patient-reported nasal congestion. Another study, in 2015, involving more than 500 adults with seasonal allergic rhinitis, came to the same conclusion.

Also, in 2015, professors of pharmacy from the University of Florida, who were part of the 2007 group that petitioned the FDA, filed a Citizens’ Petition with the FDA, asking the agency to remove phenylephrine from OTC nasal decongestant drug products because it doesn’t work. In 2022, the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology issued a statement of support for the Citizens’ Petition.

Finally, on September 11 and 12, 2023, an advisory committee to the FDA reviewed data and clinical trials that were presented in an 89-page report and concluded that orally administered phenylephrine doesn’t relieve nasal congestion. This left many consumers wondering, Why is this drug on pharmacy shelves if it doesn’t work? 

One of the likely reasons: “A safety issue was not raised with this—it’s an effectiveness issue,” says Mark Dykewicz, chief of allergy and immunology at the Saint Louis University School of Medicine who was a member of the FDA non-prescription drug panel that reviewed the data. “The data doesn’t show effectiveness, and I haven’t personally recommended it for years,” he says.

A troubled history

One reason this drug evaded rigorous evaluation is that phenylephrine was patented in 1927 and came into use before World War II. Over the years, it has been used, in different formulations, to treat nasal congestion, hemorrhoids, and priapism (a disorder involving involuntary, prolonged erections of the penis), as well as to dilate pupils or increase blood pressure in ill patients with hypotension.

But it wasn’t until 1976 when the FDA began reviewing OTC cold medicines that it granted phenylephrine “Generally Recognized as Safe and Effective” (GRASE) status as a decongestant.

The GRASE designation was based on “studies that were done in a different era that would not meet our modern standards,” explains Dykewicz. “It was really de facto grandfathering in phenylephrine.”

The problem is this: “When you take it by mouth, it first gets absorbed by the stomach and the liver inactivates 70 percent of it before it gets in the bloodstream,” Talmadge explains. Other studies have shown that only 1 percent of the drug becomes systemically bioavailable. Either way, this means very little of the drug ever reaches the nose, which is where it’s needed.

At one time, there were three decongestant ingredients on the market—phenylpropanolamine, pseudoephedrine (Sudafed), and phenylephrine—each of which had GRASE status. In 2005, the FDA took steps to pull phenylpropanolamine from the OTC market because the drug increased the risk of hemorrhagic strokes in women.

The following year, access to pseudoephedrine was restricted and the drug was placed behind the counter at pharmacies, requiring customers to request it, show ID, and have their purchasing habits of the drug tracked. This was to prevent people from buying large quantities and using it to manufacture methamphetamine, a highly addictive stimulant (pseudoephedrine is a chemical precursor to meth).

After that, “phenylephrine became more commonly used,” says Eli O. Meltzer, a clinical professor of pediatrics in the division of allergy and immunology at the University of California, San Diego. And many OTC multi-ingredient products were reformulated to include phenylephrine instead of pseudoephedrine.

In that respect, says Talmadge, “phenylephrine was in the right place at the right time.”

Meanwhile, phenylephrine’s quietly troubled history—not in terms of safety but as far as efficacy goes—increasingly came to light.

Nevertheless, it wasn’t until September 2023 that a significant step toward regulatory action on phenylephrine was taken. And yet, the drug still remains on the market—for now, anyway.

Experts say that while some consumers are surprised by the announcement that it isn’t effective, others aren’t.

“A lot of people already knew this from their own experience,” says Purvi Parikh, an allergist and immunologist with NYU Langone Health. Even so, she adds, “people are surprised that [the drug] is so widely used even though it was questioned as far back as 2007.”

Some experts also question why it took so long. “We’ve known for a long time that [oral] phenylephrine is ineffective,” Meltzer says.

Others have a better-late-than-never mindset. “The upshot is: We can reduce patients’ financial burden from buying products that are not effective,” says Mark Sullivan, chief pharmacy officer with Vanderbilt Health in Nashville. “The FDA is looking through the data which instills confidence for what they’re doing for public” well-being.

Weighing the options

With cold and flu season approaching, many people are wondering which OTC medicines to stock up on and which ones to ditch. Now, only one of the original three OTC oral decongestants is still available and considered effective: Pseudoephedrine, the one that’s kept behind the pharmacy counter, is the only one that’s acknowledged to work safely.

Even with the news that the oral form of phenylephrine doesn’t relieve nasal congestion, “some people have really strong attachments to some of these medications and think they work,” says Talmadge. “There could be a placebo effect to some of these.” Which means there’s no need to panic and purge your medicine cabinet of any product containing phenylephrine if it helps you.

It’s worth noting that while the FDA advisory committee agreed that when it’s taken orally phenylephrine doesn’t work, the committee didn’t discuss other delivery systems such as nasal sprays. When the drug is used in sprays, drops, or IVs, “phenylephrine works really well,” says Talmadge.

Still, many doctors say that OTC nasal steroid sprays (such as Flonase, Nasacort, and Nasonex) are the most effective approach for reducing nasal inflammation and congestion. But “they don’t work immediately—you have to use them every day,” Talmadge says. Nasal antihistamine sprays (like Astepro) also can be helpful for nasal congestion that’s due to allergies or colds, Parikh says.

In general, “people prefer oral decongestants over nasal sprays,” Dykewicz adds. But “if oral decongestants aren’t getting the job done, nasal sprays can do much better.”

If you want something that works quickly, you can buy oral pseudoephedrine (such as Sudafed) at the pharmacy counter or get an OTC nasal spray with phenylephrine (like Afrin), which is effective in shrinking swollen blood vessels in the nose, Meltzer says.

But neither of these ingredients should be used for more than five days (a cautionary note mentioned on the package label) because they can increase the risk of rebound congestion: As the medication wears off, the nasal passages swell, causing you to feel even more congested than you did previously, explains Princess Ogbogu, division chief of allergy and immunology at Case Western Hospitals in Cleveland. Plus, oral pseudoephedrine can cause problematic side effects such as increased heart rate or palpitations, spikes in blood pressure, or difficulty sleeping.

Another concern with nasal phenylephrine sprays: “Because they’re over the counter, people don’t know when to stop using them,” Parikh says. “If they use it too long, they can damage the lining of the nose and even get perforations with overuse.”

Instead, nasal irrigation with an OTC saline spray or a Neti pot can be helpful in reducing nasal congestion. Just be sure to use distilled water or tap water that has been boiled and cooled to prevent contamination from a water-based amoeba that can lead to brain infections, Dykewicz says.

What’s next for phenylephrine?  

So far, the FDA hasn’t removed oral phenylephrine from the market, in the wake of the advisory committee meeting in September, and there isn’t an immediate timeline for making the decision on whether to do so.

Down the road, however, the FDA could issue an order to remove the ingredient from the market, in which case the public would have an opportunity to comment on the issue before next steps are taken.

Ultimately, if the FDA decides to revoke phenylephrine’s GRASE designation, the agency could pull it from the market after working with manufacturers to reformulate products with other ingredients that would effectively treat symptoms of colds or allergies. This would help prevent the cold and sinus aisle of the pharmacy from becoming a wasteland.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : National Geographic – https://www.nationalgeographic.com/premium/article/decongestant-medicine-phenylephrine-useless

Tags: phenylephrinescienceScientists
Previous Post

Gamma Inks Partnership Deal With Rick Ross and Maybach Music, Adds Breyon Prescott to Executive Roster

Next Post

How a commuter bridge turned into a bucket-list experience

Trump Designates Antifa ‘Terror Organisation’ Days After Charlie Kirk Murder – NDTV

Trump Designates Antifa ‘Terror Organisation’ Days After Charlie Kirk Murder – NDTV

September 18, 2025
Study: UIS contributes nearly $1 billion to the Illinois economy – NPR Illinois

Study: UIS contributes nearly $1 billion to the Illinois economy – NPR Illinois

September 18, 2025
REO to return for UI homecoming – The News-Gazette

REO Gears Up to Ignite the Stage at UI Homecoming Celebration!

September 18, 2025
WATCH: Former CDC doctor says U.S. is on track to see uptick in preventable diseases under Kennedy – PBS

WATCH: Former CDC Doctor Warns of Rising Preventable Diseases in the U.S

September 18, 2025
Local politicians, judges, officials face increased threats, new data shows – WDSU

Local politicians, judges, officials face increased threats, new data shows – WDSU

September 18, 2025
Washington State Honors Hanford Team for Protecting Native Habitat – Department of Energy (.gov)

Washington State Celebrates Hanford Team’s Success in Protecting Native Habitat

September 17, 2025
Kent State University unveils poetry inspired by science despite federal funding cut – Ideastream

Kent State University Unveils Science-Inspired Poetry Amid Federal Funding Cuts

September 17, 2025
Fired CDC director warns of backslide in US vaccine science under RFK Jr – Al Jazeera

Fired CDC director warns of backslide in US vaccine science under RFK Jr – Al Jazeera

September 17, 2025
Melting Pot Brings Back Its Most ‘Luxurious’ Fondue for a Limited Time – yahoo.com

Melting Pot Brings Back Its Most ‘Luxurious’ Fondue for a Limited Time – yahoo.com

September 17, 2025
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today – Crowell & Moring LLP

September 17, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (824)
  • Economy (844)
  • Entertainment (21,723)
  • General (17,097)
  • Health (9,889)
  • Lifestyle (858)
  • News (22,149)
  • People (848)
  • Politics (854)
  • Science (16,055)
  • Sports (21,344)
  • Technology (15,826)
  • World (828)

Recent News

Trump Designates Antifa ‘Terror Organisation’ Days After Charlie Kirk Murder – NDTV

Trump Designates Antifa ‘Terror Organisation’ Days After Charlie Kirk Murder – NDTV

September 18, 2025
Study: UIS contributes nearly $1 billion to the Illinois economy – NPR Illinois

Study: UIS contributes nearly $1 billion to the Illinois economy – NPR Illinois

September 18, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version